Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 16, Issue 1, 2001, Pages 111-114

  Movilli, Ezio ^a,b   Cancarini, Giovanni Carlo ^a   Zani, Roberta ^a   Camerini, Corrado ^a   Sandrini, Massimo ^a   Maiorca, Rosario ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SPEDALI CIVILI   (Italy)

Author keywords

Adequacy; Anaemia; Biocompatibility; Epo dose; Haemodialysis

Indexed keywords

ALBUMIN; BICARBONATE; CELLULOSE; FERRITIN; HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; BLEEDING; BLOOD TRANSFUSION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIALYSIS; DIALYSIS MEMBRANE; DRUG COST; FEMALE; HEMATOCRIT; HEMODIALYSIS PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; IRON DEFICIENCY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL;

EID: 0035164804     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.1.111     Document Type: Article

References (21)

1. The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
2. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial
3. Recombinant human erythropoietin in anemic patients with end-stage renal disease: Results of a phase III multicenter clinical trial
4. Optimal haemoglobin during treatment with recombinant erythropoietin
5. Poor response to erythropoietin: Practical guideline on investigation and management
6. R-HuEpo hyporesponsiveness Who and why?
7. Evidence-based recommendations for the clinical use of recombinant human erythropoietin
8. The urea reduction ratio and serum albumin concentrations as predictors of mortality in patients undergoing hemodialysis
9. The dose of hemodialysis and patient mortality
10. Dialysis dose, membrane type, and anemia control
11. European best practice guidelines for the management of anaemia in patients with chronic renal failure
12. Total body water volumes for adult males and females estimated from simple anthropometric measurements
13. Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error
14. US multicenter clinical trial with recombinant human erythropoietin
15. A randomized controlled study of iron supplementation in patients treated with erythropoietin
16. Predictors of target hematocrit among erythropoietin-treated HD patients
17. NKF-DOQI clinical practice guidelines for hemodialysis adequacy
18. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease
19. Identification of spermine as an inhibitor of erythropoiesis in patients with chronic renal failure
20. Uremic toxicity: The middle molecule hypothesis revisited